242 related articles for article (PubMed ID: 28956198)
1. Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets.
Ayoub KF; Pothineni NVK; Rutland J; Ding Z; Mehta JL
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):593-608. PubMed ID: 28956198
[TBL] [Abstract][Full Text] [Related]
2. Inflammation in Heart Failure: known knowns and unknown unknowns.
Cocco G; Jerie P; Amiet P; Pandolfi S
Expert Opin Pharmacother; 2017 Aug; 18(12):1225-1233. PubMed ID: 28679294
[TBL] [Abstract][Full Text] [Related]
3. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure.
Khaper N; Bryan S; Dhingra S; Singal R; Bajaj A; Pathak CM; Singal PK
Antioxid Redox Signal; 2010 Oct; 13(7):1033-49. PubMed ID: 20380580
[TBL] [Abstract][Full Text] [Related]
4. Immune mechanisms in heart failure.
Zhang Y; Bauersachs J; Langer HF
Eur J Heart Fail; 2017 Nov; 19(11):1379-1389. PubMed ID: 28891154
[TBL] [Abstract][Full Text] [Related]
5. The Endothelium as a Target for the Treatment of Heart Failure.
Yang O; Li J; Kong J
Cell Biochem Biophys; 2015 Jul; 72(3):751-6. PubMed ID: 25616442
[TBL] [Abstract][Full Text] [Related]
6. Protective Role of Polyphenols in Heart Failure: Molecular Targets and Cellular Mechanisms Underlying Their Therapeutic Potential.
Najjar RS; Feresin RG
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562294
[TBL] [Abstract][Full Text] [Related]
7. Role of Adaptive Immunity in the Development and Progression of Heart Failure: New Evidence.
Sánchez-Trujillo L; Vázquez-Garza E; Castillo EC; García-Rivas G; Torre-Amione G
Arch Med Res; 2017 Jan; 48(1):1-11. PubMed ID: 28577862
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targets in heart failure: refocusing on the myocardial interstitium.
Schelbert EB; Fonarow GC; Bonow RO; Butler J; Gheorghiade M
J Am Coll Cardiol; 2014 Jun; 63(21):2188-98. PubMed ID: 24657693
[TBL] [Abstract][Full Text] [Related]
9. Drug therapy of heart failure: an immunologic view.
El Desoky ES
Am J Ther; 2011 Sep; 18(5):416-25. PubMed ID: 20592661
[TBL] [Abstract][Full Text] [Related]
10. Targeting Key Inflammatory Mechanisms Underlying Heart Failure: A Comprehensive Review.
Papamichail A; Kourek C; Briasoulis A; Xanthopoulos A; Tsougos E; Farmakis D; Paraskevaidis I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203681
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cytokines in heart failure: mediators and markers.
Gullestad L; Ueland T; Vinge LE; Finsen A; Yndestad A; Aukrust P
Cardiology; 2012; 122(1):23-35. PubMed ID: 22699305
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors as therapeutic targets for heart failure.
Abushouk AI; El-Husseny MWA; Bahbah EI; Elmaraezy A; Ali AA; Ashraf A; Abdel-Daim MM
Biomed Pharmacother; 2017 Nov; 95():692-700. PubMed ID: 28886529
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.
Beccastrini E; D'Elios MM; Emmi G; Silvestri E; Squatrito D; Prisco D; Emmi L
Int J Immunopathol Pharmacol; 2013; 26(3):585-96. PubMed ID: 24067455
[TBL] [Abstract][Full Text] [Related]
14. Structural and electrical remodeling as therapeutic targets in heart failure.
Cutler MJ; Rosenbaum DS; Dunlap ME
J Electrocardiol; 2007; 40(6 Suppl):S1-7. PubMed ID: 17993305
[TBL] [Abstract][Full Text] [Related]
15. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic targets for the development of positive inotropic agents.
Tamargo J; Duarte J; Caballero R; Delpón E
Discov Med; 2011 Nov; 12(66):381-92. PubMed ID: 22127109
[TBL] [Abstract][Full Text] [Related]
17. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
Marchioli R; Silletta MG; Levantesi G; Pioggiarella R; Tognoni G
Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):110-30. PubMed ID: 20196975
[TBL] [Abstract][Full Text] [Related]
18. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
19. Role of inflammation in the progression of heart failure.
Yndestad A; Damås JK; Øie E; Ueland T; Gullestad L; Aukrust P
Curr Cardiol Rep; 2007 May; 9(3):236-41. PubMed ID: 17470337
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in heart failure: pathophysiology and therapeutic strategies.
Boulet J; Sridhar VS; Bouabdallaoui N; Tardif JC; White M
Inflamm Res; 2024 May; 73(5):709-723. PubMed ID: 38546848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
